Taiwan may be dominating global headlines this week over the reactions to US House Speaker Nancy Pelosi’s controversial visit, but for the global pharma industry already operating there, it was issues around local clinical trials that came into focus at a recent conference.
The island has long been viewed by the international pharma industry as having international-level investigator expertise and facilities, with R&D...